Perkins Coie Trust Company’s Vertex Pharmaceuticals VRTX Stock Holding History

Perkins Coie Trust Company’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$47.2K	Buy	+95	New	+$42.1K	0.01%	169
2025 Q2	–	Sell	-1	Closed	-$484	–	468
2025 Q1	$484	Buy	+1	New	+$466	﹤0.01%	343
2024 Q2	–	Sell	-4	Closed	-$1.67K	–	296
2024 Q1	$1.67K	Hold	4	–	–	﹤0.01%	228
2023 Q4	$1.63K	Sell	4 -3	-43%	-$1.11K	﹤0.01%	238
2023 Q3	$2.43K	Buy	+7	New	+$2.45K	﹤0.01%	326
2020 Q2	–	Sell	-3	Closed	-$1K	–	430
2020 Q1	$1K	Buy	+3	New	+$688	﹤0.01%	322

Other funds holding VRTX

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

CTB

Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return

PensionDanmark Copenhagen O, Denmark $12B AUM

BIAS

Beacon Investment Advisory Services Morristown, New Jersey $2.69B AUM 35.07% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Perkins Coie Trust Company's VRTX Position: Q2 2026 in Review

Perkins Coie Trust Company opened a new position in Vertex Pharmaceuticals (VRTX) in Q2 2026: 95 shares worth $47.2K. The stake represents 0.01% of the portfolio and ranks #169 among its holdings. This is a return to the name: Perkins Coie Trust Company previously reported a position in VRTX as recently as Q1 2025.

Perkins Coie Trust Company first reported a position in VRTX in Q1 2020 and has held it in 6 quarters since. 229 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

Perkins Coie Trust Company held 95 shares of Vertex Pharmaceuticals worth $47.2K as of Q2 2026.
Vertex Pharmaceuticals was a new Perkins Coie Trust Company position in Q2 2026.
Vertex Pharmaceuticals made up 0.01% of Perkins Coie Trust Company's portfolio in Q2 2026, its #169 holding.
Perkins Coie Trust Company first reported a position in Vertex Pharmaceuticals in Q1 2020 and has held it in 6 quarters since.
229 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Perkins Coie Trust Company's 13F filing for Q2 2026, filed 9 Jul 2026.